Dawei Song

Artiklar

Article: ONCOGENE. 2022;41(4):600-611
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma
Song D; Cismas S; Crudden C; Trocme E; Worrall C; Suleymanova N; Lin T; Zheng H; Seregard S; Girnita A; Girnita L
Article: CANCER RESEARCH. 2021;81(2):501-514
Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth
Crudden C; Shibano T; Song D; Dragomir MP; Cismas S; Serly J; Nedelcu D; Fuentes-Mattei E; Tica A; Calin GA; Girnita A; Girnita L

Corrigendum: ONCOGENE. 2023;42(11):858
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (vol 41, pg 600, 2022)
Song D; Cismas S; Crudden C; Trocme E; Worrall C; Suleymanova N; Lin T; Zheng H; Seregard S; Girnita A; Girnita L
Thesis / dissertation: 2022
Old receptors learn new tricks : biasing anti-IGF1R cancer therapy through the GPCR system
Song, Dawei
Review: CELLS. 2019;8(10):E1223-1223
Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey
Crudden C; Song D; Cismas S; Trocme E; Pasca S; Calin GA; Girnita A; Girnita L
Review: CHROMATIN AND GENOMIC INSTABILITY IN CANCER. 2018;339:1-40
Blurring Boundaries: Receptor Tyrosine Kinases as functional G Protein-Coupled Receptors
Crudden C; Shibano T; Song D; Suleymanova N; Girnita A; Girnita L

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2022